Canan Küçükgergin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Canan Küçükgergin has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Şule Seçkin
Department of Medical Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
6 shared publications - Muhammet Irfan Donmez
Division of Pediatric Urology, Department of Urology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
4 shared publications - Orhan Ziylan
İstanbul University, İstanbul Faculty of Medicine, Department of Urology, Division of Pediatric Urology, Turkey
4 shared publications - Selcuk Erdem
Division of Urologic Oncology, Department of Urology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
4 shared publications - Tayfun Oktar
İstanbul University, İstanbul Faculty of Medicine, Department of Urology, Division of Pediatric Urology, Turkey; Koç University, School of Medicine, Department of Urology, Turkey
4 shared publications - Ünsal Özkuvancı
Division of Pediatric Urology, Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
3 shared publications
Latest Publications
- Open Access
Association of Ascending Aortic Aneurysm with NOX4 and miRNA 146a
Objective: To evaluate the efficacy of NADPH oxidase 4 and miR-146a-5p in current treatment planning for ascending aortic aneurysms, independent of aortic diameter, and to develop protocols that will ensure the treatment of ascending aortic aneurysms, which pose a risk for aortic dissection, without complications. Methods: Patients who met the inclusion criteria and underwent surgery at Dr. Siyami Ersek Chest, Heart, and Vascular Surgery Training and Research Hospital for ascending aortic aneurysms and coronary artery disease between 2023 and 2024 were included in the study. This study was designed as a prospective study. Demographic, biochemical, radiological, and echocardiographic data were collected, and NOX4 mRNA and miR-146a-5p expressions were examined and compared in tissue samples. Results: The study was conducted on a total of 50 patients, with 25 patients in the aneurysm group and 25 patients in the control group. miR-146a-5p expression levels were found to be significantly decreased in the patient group compared to the control group (p = 0.001). When NOX4 mRNA expression levels were examined, no significant difference was found between the control and aneurysm groups. No correlation was found between NOX4 mRNA and miR-146a-5p levels (p = 0.764). When the relationship between ascending aorta diameter and both NOX4 mRNA and miR-146a-5p was examined, it was found that miR-146a-5p expression was negatively correlated with ascending aorta diameter (p = 0.036) and did not show a significant correlation with NOX4 mRNA levels (p = 0.318). A similar correlation was also found with ascending aorta length. The correlation of NOX4 mRNA and miR-146a-5p expression levels with age, gender, and ejection fraction was investigated separately. No significant correlation was found for all three variables. The optimum cut-off value to be used to separate the patient group from the control group using miR-146a-5p expression levels, as well as the sensitivity and specificity of miR-146a-5p expression levels when this cut-off value was used, was calculated using an ROC curve. Specificity for miR-146a-5p expression was found to be 88%, and sensitivity was found to be 66%. Conclusions: The study found promising results indicating that NOX4, shown to be a determinant of vascular oxidative stress, is not involved in the development of ascending aortic aneurysms; however, miR-146a-5p, which functions in the regulation of many inflammatory responses, including the regulation of NOX4 expression, may help prevent the development of ascending aortic aneurysms. Further studies aimed at elucidating the genetic and biochemical processes involved in aneurysm development suggest that miR-146a-5p could be a therapeutic target for preventing aneurysms.
Open AccessAssociation of Ascending Aortic Aneurysm with NOX4 and miRNA 146a
Objective: To evaluate the efficacy of NADPH oxidase 4 and miR-146a-5p in current treatment planning for ascending aortic aneurysms, independent of aortic diameter, and to develop protocols that will ensure the treatment of ascending aortic aneurysms, which pose a risk for aortic dissection, without complications. Methods: Patients who met the inclusion criteria and underwent surgery at Dr. Siyami Ersek Chest, Heart, and Vascular Surgery Training and Research Hospital for ascending aortic aneurysms and coronary artery disease between 2023 and 2024 were included in the study. This study was designed as a prospective study. Demographic, biochemical, radiological, and echocardiographic data were collected, and NOX4 mRNA and miR-146a-5p expressions were examined and compared in tissue samples. Results: The study was conducted on a total of 50 patients, with 25 patients in the aneurysm group and 25 patients in the control group. miR-146a-5p expression levels were found to be significantly decreased in the patient group compared to the control group (p = 0.001). When NOX4 mRNA expression levels were examined, no significant difference was found between the control and aneurysm groups. No correlation was found between NOX4 mRNA and miR-146a-5p levels (p = 0.764). When the relationship between ascending aorta diameter and both NOX4 mRNA and miR-146a-5p was examined, it was found that miR-146a-5p expression was negatively correlated with ascending aorta diameter (p = 0.036) and did not show a significant correlation with NOX4 mRNA levels (p = 0.318). A similar correlation was also found with ascending aorta length. The correlation of NOX4 mRNA and miR-146a-5p expression levels with age, gender, and ejection fraction was investigated separately. No significant correlation was found for all three variables. The optimum cut-off value to be used to separate the patient group from the control group using miR-146a-5p expression levels, as well as the sensitivity and specificity of miR-146a-5p expression levels when this cut-off value was used, was calculated using an ROC curve. Specificity for miR-146a-5p expression was found to be 88%, and sensitivity was found to be 66%. Conclusions: The study found promising results indicating that NOX4, shown to be a determinant of vascular oxidative stress, is not involved in the development of ascending aortic aneurysms; however, miR-146a-5p, which functions in the regulation of many inflammatory responses, including the regulation of NOX4 expression, may help prevent the development of ascending aortic aneurysms. Further studies aimed at elucidating the genetic and biochemical processes involved in aneurysm development suggest that miR-146a-5p could be a therapeutic target for preventing aneurysms.
- Open Access
- 28 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (11) , 4182
ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates
Purpose: Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have emerged as important regulators of the epithelial–mesenchymal transition (EMT) and tumor progression. The present study evaluated the expression profiles of lncRNA ZEB1-AS1 and miR-200b-3p in non-muscle-invasive bladder cancer (NMIBC) tissues and investigated their associations with clinicopathological characteristics. Materials and Methods: Tumor tissues and matched adjacent normal bladder tissue were obtained from 50 patients with primary NMIBC who underwent transurethral resection of bladder tumors. Total RNA was extracted, and expression levels of ZEB1-AS1 and miR-200b-3p were measured using quantitative real-time polymerase chain reaction (qRT-PCR). Relative expression levels were calculated using the 2−ΔΔCT method. Associations between gene expression levels and clinicopathological parameters were analyzed using non-parametric statistical tests. Receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic performance. Results: ZEB1-AS1 and miR-200b-3p demonstrated significantly increased expression in tumor tissues compared with adjacent normal bladder tissue (p = 0.018 and p = 0.034, respectively). ZEB1-AS1 expression was significantly higher in high-grade tumors (p = 0.007), whereas miR-200b-3p expression was more pronounced in low-grade tumors (p = 0.015). No significant associations were identified between expression levels and tumor stage, carcinoma in situ, or variant histology. ROC analysis demonstrated modest diagnostic performance, with AUC values of 0.637 for ZEB1-AS1 and 0.624 for miR-200b-3p. Conclusions: ZEB1-AS1 and miR-200b-3p demonstrated distinct expression patterns associated with tumor grade and may contribute to EMT-associated molecular heterogeneity in NMIBC. Although the individual diagnostic performance of these markers appeared limited, the present findings provide additional insight into non-coding RNA-associated pathways and support further investigation in larger validation studies.
- 28 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (11) , 4182
Open AccessZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates
Purpose: Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have emerged as important regulators of the epithelial–mesenchymal transition (EMT) and tumor progression. The present study evaluated the expression profiles of lncRNA ZEB1-AS1 and miR-200b-3p in non-muscle-invasive bladder cancer (NMIBC) tissues and investigated their associations with clinicopathological characteristics. Materials and Methods: Tumor tissues and matched adjacent normal bladder tissue were obtained from 50 patients with primary NMIBC who underwent transurethral resection of bladder tumors. Total RNA was extracted, and expression levels of ZEB1-AS1 and miR-200b-3p were measured using quantitative real-time polymerase chain reaction (qRT-PCR). Relative expression levels were calculated using the 2−ΔΔCT method. Associations between gene expression levels and clinicopathological parameters were analyzed using non-parametric statistical tests. Receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic performance. Results: ZEB1-AS1 and miR-200b-3p demonstrated significantly increased expression in tumor tissues compared with adjacent normal bladder tissue (p = 0.018 and p = 0.034, respectively). ZEB1-AS1 expression was significantly higher in high-grade tumors (p = 0.007), whereas miR-200b-3p expression was more pronounced in low-grade tumors (p = 0.015). No significant associations were identified between expression levels and tumor stage, carcinoma in situ, or variant histology. ROC analysis demonstrated modest diagnostic performance, with AUC values of 0.637 for ZEB1-AS1 and 0.624 for miR-200b-3p. Conclusions: ZEB1-AS1 and miR-200b-3p demonstrated distinct expression patterns associated with tumor grade and may contribute to EMT-associated molecular heterogeneity in NMIBC. Although the individual diagnostic performance of these markers appeared limited, the present findings provide additional insight into non-coding RNA-associated pathways and support further investigation in larger validation studies.
- 25 June 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-10
Expression patterns and clinical relevance of H19, miR-181a-3p, and TGF-β in ascending aortic aneurysms: a comparative analysis of human aortic tissue
- 25 June 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-10
Expression patterns and clinical relevance of H19, miR-181a-3p, and TGF-β in ascending aortic aneurysms: a comparative analysis of human aortic tissue
- 1 February 2022
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 18 (1) , 6-12
Urinary biomarkers can identify the need for pyeloplasty in presence of supranormal differential renal function in antenatally diagnosed unilateral hydronephrosis
- 1 February 2022
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 18 (1) , 6-12
Urinary biomarkers can identify the need for pyeloplasty in presence of supranormal differential renal function in antenatally diagnosed unilateral hydronephrosis
- 31 January 2022
- Published by Springer Nature in Pediatric Surgery International
- Vol. 38 (3) , 499-503
Urinary HSP70 can predict the indication of surgery in unilateral ureteropelvic junction obstruction
Background Distinguishing hydronephrosis that requires surgical intervention is a clinical challenge. The aim of this study is to determine the level of urinary heat shock protein 70 (HSP70) in children who required surgery for ureteropelvic junction obstruction and its potential use as a biomarker for prediction of surgery in children with isolated unilateral hydronephrosis. Methods The data of 43 children with ureteropelvic junction obstruction who underwent pyeloplasty, 25 patients with non-obstructive dilation (NOD) and 30 healthy children (control group) were collected prospectively for this study. Preoperative and postoperative urinary HSP70/Cr levels were also analyzed in 30 children in the pyeloplasty group who had available follow-up information. HSP70 levels were assessed using ELISA. Results The median age of the pyeloplasty group was 13 months (IQR 7–36 months), NOD group was 42.5 months (IQR 16–73) and it was 36 months (IQR 24–47.5) in the control group. The mean preoperative urinary HSP70/Cr was significantly higher in the pyeloplasty group when compared to controls as well as the NOD group (150.6 pg/mgCr vs. 65.0 pg/mgCr and vs. 64.7 pg/mgCr, p < 0.001 and p < 0.001, respectively). The urinary HSP70 levels significantly decreased in the postoperative period (151.5 vs 79.5, p < 0.001). Using the cutoff value of 94.7 pg/mgCr, the sensitivity and specificity of urinary HSP70 for predicting the risk of surgical intervention were 69.7% and 68%, respectively (AUC = 0.689). Conclusion Urinary HSP70 may be used as an adjunct tool to clinical parameters to identify patients that would require surgery due to ureteropelvic junction obstruction.
- 31 January 2022
- Published by Springer Nature in Pediatric Surgery International
- Vol. 38 (3) , 499-503
Urinary HSP70 can predict the indication of surgery in unilateral ureteropelvic junction obstruction
Background Distinguishing hydronephrosis that requires surgical intervention is a clinical challenge. The aim of this study is to determine the level of urinary heat shock protein 70 (HSP70) in children who required surgery for ureteropelvic junction obstruction and its potential use as a biomarker for prediction of surgery in children with isolated unilateral hydronephrosis. Methods The data of 43 children with ureteropelvic junction obstruction who underwent pyeloplasty, 25 patients with non-obstructive dilation (NOD) and 30 healthy children (control group) were collected prospectively for this study. Preoperative and postoperative urinary HSP70/Cr levels were also analyzed in 30 children in the pyeloplasty group who had available follow-up information. HSP70 levels were assessed using ELISA. Results The median age of the pyeloplasty group was 13 months (IQR 7–36 months), NOD group was 42.5 months (IQR 16–73) and it was 36 months (IQR 24–47.5) in the control group. The mean preoperative urinary HSP70/Cr was significantly higher in the pyeloplasty group when compared to controls as well as the NOD group (150.6 pg/mgCr vs. 65.0 pg/mgCr and vs. 64.7 pg/mgCr, p < 0.001 and p < 0.001, respectively). The urinary HSP70 levels significantly decreased in the postoperative period (151.5 vs 79.5, p < 0.001). Using the cutoff value of 94.7 pg/mgCr, the sensitivity and specificity of urinary HSP70 for predicting the risk of surgical intervention were 69.7% and 68%, respectively (AUC = 0.689). Conclusion Urinary HSP70 may be used as an adjunct tool to clinical parameters to identify patients that would require surgery due to ureteropelvic junction obstruction.
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 124-125
Response to letter to the editor re ‘Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?’
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 124-125
Response to letter to the editor re ‘Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?’
- 1 December 2020
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 16 (6) , 844.e1-844.e7
Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?
- 1 December 2020
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 16 (6) , 844.e1-844.e7
Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?
- Open Access
- 6 March 2014
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 9 (1) , 12
Diagnostic utility of serum and pleural levels of adenosine deaminase 1–2, and interferon-γ in the diagnosis of pleural tuberculosis
To evaluate and compare the diagnostic efficiency of serum (s) and pleural (p) levels of adenosine deaminase (ADA)-1, ADA-2, total ADA, and interferon-gamma (IFN-γ) for the differential diagnosis of pleural tuberculosis (TB).
- 6 March 2014
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 9 (1) , 12
Open AccessDiagnostic utility of serum and pleural levels of adenosine deaminase 1–2, and interferon-γ in the diagnosis of pleural tuberculosis
To evaluate and compare the diagnostic efficiency of serum (s) and pleural (p) levels of adenosine deaminase (ADA)-1, ADA-2, total ADA, and interferon-gamma (IFN-γ) for the differential diagnosis of pleural tuberculosis (TB).